| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Anirban Ray, Santanu Munsh. Augmenting amisulpride with clozapine had led to unmasking of akathisia. Industrial psychiatry journal. vol 21. issue 2. 2013-11-19. PMID:24250050. |
amisulpride is a newer antipsychotic, which is very effective on its own, as well as augmenting other antipsychotic clozapine, which is an effective molecule for treatment resistant schizophrenia. |
2013-11-19 |
2023-08-12 |
Not clear |
| Li-jun Li, De-wei Shang, Wen-biao Li, Wei Guo, Xi-pei Wang, Yu-peng Ren, An-ning Li, Pei-xin Fu, Shuang-min Ji, Wei Lu, Chuan-yue Wan. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia. Acta pharmacologica Sinica. vol 33. issue 11. 2013-11-07. PMID:22820910. |
population pharmacokinetics of clozapine and its primary metabolite norclozapine in chinese patients with schizophrenia. |
2013-11-07 |
2023-08-12 |
Not clear |
| Li-jun Li, De-wei Shang, Wen-biao Li, Wei Guo, Xi-pei Wang, Yu-peng Ren, An-ning Li, Pei-xin Fu, Shuang-min Ji, Wei Lu, Chuan-yue Wan. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia. Acta pharmacologica Sinica. vol 33. issue 11. 2013-11-07. PMID:22820910. |
to develop a combined population pharmacokinetic model (ppk) to assess the magnitude and variability of exposure to both clozapine and its primary metabolite norclozapine in chinese patients with refractory schizophrenia via sparse sampling with a focus on the effects of covariates on the pharmacokinetic parameters. |
2013-11-07 |
2023-08-12 |
Not clear |
| Kazeem Olaide Adebayo, Nurudeen Ibrahim, Temilola Mosanya, Benjamin Eegunranti, Babatunde Suleiman, Akeem Ayankunl. Life-threatening haematemesis associated with clozapine: a case report and literature review. Therapeutic advances in psychopharmacology. vol 3. issue 5. 2013-10-29. PMID:24167703. |
the patient was a 46-year-old male being managed for chronic schizophrenia with treatment resistance who developed sudden severe haematemesis following commencement of clozapine for 6 weeks. |
2013-10-29 |
2023-08-12 |
Not clear |
| Gursharan Lal Kashyap, Jitendra Nayar, Adnan Bashier, Soosamma Varghes. Treatment of clozapine-induced priapism by goserline acetate injection. Therapeutic advances in psychopharmacology. vol 3. issue 5. 2013-10-29. PMID:24167706. |
clozapine (denzapine) is a treatment for resistant schizophrenia. |
2013-10-29 |
2023-08-12 |
Not clear |
| Chian-Jue Kuo, Shu-Yu Yang, Ya-Tang Liao, Wei J Chen, Wen-Chung Lee, Wen-Yi Shau, Yao-Tung Chang, Shang-Ying Tsai, Chiao-Chicy Che. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophrenia bulletin. vol 39. issue 3. 2013-10-28. PMID:22282455. |
clinicians who prescribe clozapine to patients with schizophrenia should closely monitor them for pneumonia, particularly at the start of therapy and when clozapine is combined with other antipsychotics. |
2013-10-28 |
2023-08-12 |
Not clear |
| Taro Kishi, Kiyoshi Fujita, Osamu Furukawa, Tatsuyo Suzuki, Masatsugu Moriwaki, Mari Nitta, Miho Hattori, Tomoko Tsunoka, Raja Chekuri, John M Kane, Christoph U Correll, Nakao Iwat. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. Asian journal of psychiatry. vol 6. issue 3. 2013-10-17. PMID:23642976. |
efficacy and tolerability of clozapine in japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. |
2013-10-17 |
2023-08-12 |
Not clear |
| Taro Kishi, Kiyoshi Fujita, Osamu Furukawa, Tatsuyo Suzuki, Masatsugu Moriwaki, Mari Nitta, Miho Hattori, Tomoko Tsunoka, Raja Chekuri, John M Kane, Christoph U Correll, Nakao Iwat. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. Asian journal of psychiatry. vol 6. issue 3. 2013-10-17. PMID:23642976. |
japan approved clozapine for treatment-resistant schizophrenia in june 2009. |
2013-10-17 |
2023-08-12 |
Not clear |
| Taro Kishi, Kiyoshi Fujita, Osamu Furukawa, Tatsuyo Suzuki, Masatsugu Moriwaki, Mari Nitta, Miho Hattori, Tomoko Tsunoka, Raja Chekuri, John M Kane, Christoph U Correll, Nakao Iwat. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. Asian journal of psychiatry. vol 6. issue 3. 2013-10-17. PMID:23642976. |
a twelve-week, single-arm clinical trial of clozapine in treatment-resistant schizophrenia inpatients, was conducted under real-world conditions using raters masked for type of antipsychotic. |
2013-10-17 |
2023-08-12 |
Not clear |
| Taro Kishi, Kiyoshi Fujita, Osamu Furukawa, Tatsuyo Suzuki, Masatsugu Moriwaki, Mari Nitta, Miho Hattori, Tomoko Tsunoka, Raja Chekuri, John M Kane, Christoph U Correll, Nakao Iwat. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. Asian journal of psychiatry. vol 6. issue 3. 2013-10-17. PMID:23642976. |
these findings suggest that clozapine is beneficial in japanese treatment-resistant schizophrenia patients. |
2013-10-17 |
2023-08-12 |
Not clear |
| Ken Inada, Jun Ishigook. [Clozapine]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678599. |
clozapine is a drug used in the management of treatment-resistant schizophrenia. |
2013-09-25 |
2023-08-12 |
Not clear |
| Ken Inada, Jun Ishigook. [Clozapine]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678599. |
therefore, in japan, clozapine is approved for administration to only patients with treatment-resistant schizophrenia in whom treatment with other antipsychotic drugs was ineffective. |
2013-09-25 |
2023-08-12 |
Not clear |
| Minoru Takebayash. [Electroconvulsive therapy in schizophrenia]. Nihon rinsho. Japanese journal of clinical medicine. vol 71. issue 4. 2013-09-25. PMID:23678602. |
therefore, a combination of ect with pharmacotherapy including clozapine may be effective for the pharmacotherapy -resistant schizophrenia. |
2013-09-25 |
2023-08-12 |
Not clear |
| Marcela Horvitz-Lennon, Julie M Donohue, Judith R Lave, Margarita Alegría, Sharon-Lise T Norman. The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries. Psychiatric services (Washington, D.C.). vol 64. issue 3. 2013-09-19. PMID:23242347. |
effectiveness trials have confirmed the superiority of clozapine in schizophrenia treatment, but little is known about whether the drug's superiority holds across racial-ethnic groups. |
2013-09-19 |
2023-08-12 |
Not clear |
| Tariq Munshi, Mir Mazhar, Tariq Hassa. Clozapine reinitiation following a "red result" secondary to chemotherapy. Neuropsychiatric disease and treatment. vol 9. 2013-09-16. PMID:24039428. |
clinicians are reluctant to prescribe clozapine in view of its side-effect profile, despite its proven efficacy for managing treatment-resistant schizophrenia. |
2013-09-16 |
2023-08-12 |
Not clear |
| Michelle Wilson, John Brett Offenberge. Intermittent neutropenia and leucopenia unrelated to clozapine in a 12-year-old girl with schizophrenia. Journal of child and adolescent psychopharmacology. vol 23. issue 2. 2013-09-13. PMID:23480326. |
intermittent neutropenia and leucopenia unrelated to clozapine in a 12-year-old girl with schizophrenia. |
2013-09-13 |
2023-08-12 |
Not clear |
| Frederike Schirmbeck, Franziska Rausch, Susanne Englisch, Sarah Eifler, Christine Esslinger, Andreas Meyer-Lindenberg, Mathias Zin. Differential effects of antipsychotic agents on obsessive-compulsive symptoms in schizophrenia: a longitudinal study. Journal of psychopharmacology (Oxford, England). vol 27. issue 4. 2013-09-09. PMID:23095245. |
over 12 months, we followed-up 75 schizophrenia patients who were classified into two groups according to antipsychotic treatment: clozapine or olanzapine (group i) versus aripiprazole or amisulpride (group ii). |
2013-09-09 |
2023-08-12 |
Not clear |
| John Lally, Anne Gallagher, Emma Bainbridge, Gloria Avalos, Mohamed Ahmed, Colm McDonal. Increases in triglyceride levels are associated with clinical response to clozapine treatment. Journal of psychopharmacology (Oxford, England). vol 27. issue 4. 2013-09-09. PMID:23325369. |
in this prospective observational study, we examine associations between therapeutic response to clozapine in 49 patients with treatment-resistant schizophrenia and lipid dysregulation. |
2013-09-09 |
2023-08-12 |
Not clear |
| Domenico De Berardis, Nicola Serroni, Daniela Campanella, Luigi Olivieri, Stefano Marini, Francesco Saverio Moschetta, Giovanni Martinotti, Massimo Di Giannantoni. Safety and efficacy of combined clozapine-azathioprine treatment in a case of resistant schizophrenia associated with Behçet's disease: a 2-year follow-up. General hospital psychiatry. vol 35. issue 2. 2013-09-03. PMID:22819722. |
we here report on a 37-year-old man with bd and treatment-resistant schizophrenia who obtained an improvement following the introduction of clozapine in addition to azathioprine, without developing agranulocytosis or other severe adverse side effects during a 2-year follow-up. |
2013-09-03 |
2023-08-12 |
Not clear |
| Tomiki Sumiyosh. Antipsychotic treatments; focus on lurasidone. Frontiers in pharmacology. vol 4. 2013-08-29. PMID:23986702. |
the introduction of atypical antipsychotic drugs (aapds), or second-generation antipsychotics, with clozapine as the prototype, has largely changed the clinicians' attitudes toward the treatment of mental illnesses including, but not limited to schizophrenia. |
2013-08-29 |
2023-08-12 |
Not clear |